Next-Generation Rational Drug Design: Momed Biotech Unveils PAM-DB, the World's First Database on Target Protein Activation Mechanisms

Great News! Dr. Bai Chen, Founder of MoMed Biotech, Honored as a 2026 Zhejiang Provincial Young Tech Entrepreneur

MoMed Biotech enters strategic cooperation with Qilu Pharmaceutical, embarking on a new journey of AI-driven innovative drug R&D

MoMed Biotech Listed on 2026 Zhejiang "Seed Unicorn" List.

Joincare Vice President Tang Tingke Visits MoMed Biotech, Forging New Consensus on Deeper AI-Driven Drug Development Collaboration